Franklin Resources
SNDX icon

Franklin Resources’s Syndax Pharmaceuticals SNDX Stock Holding History

Franklin Resources’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50M Buy
2,286,499
+136,420
+6% +$2.84M 0.01% 683
2026
Q1 		$50.2M Sell
2,150,079
-271,587
-11% -$5.9M 0.01% 648
2025
Q4 		$50.9M Buy
2,421,666
+31,105
+1% +$543K 0.01% 633
2025
Q3 		$36.8M Buy
2,390,561
+30,884
+1% +$404K 0.01% 738
2025
Q2 		$22.1M Buy
2,359,677
+298,272
+14% +$3.28M 0.01% 899
2025
Q1 		$25.3M Buy
2,061,405
+294,546
+17% +$4.15M 0.01% 832
2024
Q4 		$23.4M Buy
1,766,859
+3,582
+0.2% +$61.3K 0.01% 854
2024
Q3 		$34.9M Buy
1,763,277
+208,043
+13% +$4.3M 0.01% 709
2024
Q2 		$31.9M Buy
1,555,234
+59,529
+4% +$1.25M 0.01% 704
2024
Q1 		$35.6M Buy
1,495,705
+142,800
+11% +$3.18M 0.01% 686
2023
Q4 		$29.2M Buy
+1,352,905
New +$20.8M 0.01% 657

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Franklin Resources's SNDX Position: Q2 2026 in Review

Franklin Resources increased its Syndax Pharmaceuticals (SNDX) stake by 6.3% in Q2 2026, buying an estimated $2.84M and bringing the position to 2,286,499 shares worth $50M. The position accounts for 0.01% of the portfolio, ranked #683.

Franklin Resources first reported a position in SNDX in Q4 2023 and has held it in 11 quarters since. The position peaked at $50.9M in Q4 2025. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Franklin Resources held 2,286,499 shares of Syndax Pharmaceuticals worth $50M as of Q2 2026.
  • Franklin Resources bought 136,420 Syndax Pharmaceuticals shares in Q2 2026, an estimated $2.84M.
  • Syndax Pharmaceuticals made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #683 holding.
  • Franklin Resources first reported a position in Syndax Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Franklin Resources's Syndax Pharmaceuticals position peaked at $50.9M in Q4 2025.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.